Influence of metabolic risk factors on the presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease
Ljubica Georgievska-Ismail
Diabetes & Vascular Disease Research, 2007
View PDFchevron_right
Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Healt...
binh phan
Arteriosclerosis, thrombosis, and vascular biology, 2018
View PDFchevron_right
Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease
Andre Van Rij
Clinical Chemistry, 2007
View PDFchevron_right
Frequency and characteristics of metabolic syndrome in patients with symptomatic carotid atherosclerosis
jagoda jorga
Revista Medica De Chile, 2009
View PDFchevron_right
Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up
Spomenka Ljubic
Wiener klinische Wochenschrift, 2010
View PDFchevron_right
Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study
aleksandra pikula
Neurology, 2015
View PDFchevron_right
Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample
Bertrand Perret
Atherosclerosis, 2006
View PDFchevron_right
The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions
Bo Hedblad
Diabetic Medicine, 2007
View PDFchevron_right
Lp-PLA(2) activity and mass are associated with increased incidence of ischemic stroke - A population-based cohort study from Malmo, Sweden
Bo Hedblad
Atherosclerosis, 2008
View PDFchevron_right
Metabolic syndrome and restenosis of carotid artery
Djordje Radak
Vojnosanitetski pregled, 2014
View PDFchevron_right
Components of the Metabolic Syndrome and Carotid Atherosclerosis: Role of Elevated Blood Pressure
Giorgio Sesti
Hypertension, 2005
View PDFchevron_right
The Epidemiology of LpPLA2: Distribution and Correlation with Cardiovascular Risk Factors in a Population-based Cohort
Margaretha Persson, Bo Hedblad
2000
View PDFchevron_right
Lipids and carotid plaque in the Northern Manhattan Study (NOMAS)
Tatjana Rundek
BMC Cardiovascular Disorders, 2009
View PDFchevron_right
Lipoprotein(a): an emerging cardiovascular risk factor in hypertensive patients
Maria-Corina Serban
View PDFchevron_right
Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease
Otto Mayer, Peter Wohlfahrt
European Journal of Internal Medicine, 2014
View PDFchevron_right
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
Ingmar Jungner
JAMA, 2009
View PDFchevron_right
Causal Relevance of Blood Lipid Fractions in the Development of Carotid Atherosclerosis
Damiano Baldassarre
Circulation-cardiovascular Genetics, 2013
View PDFchevron_right
“Not all forms of NAFLD were created equal”. Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?
Giovanni Targher
Atherosclerosis, 2017
View PDFchevron_right
The relationship between dietary patterns and lipoprotein-associated phospholipase A2 levels in adults with cardiovascular risk factors: Tehran Lipid and Glucose Study
azadeh mottaghi
Journal of Research in Medical Sciences, 2020
View PDFchevron_right
Serum insulin levels are associated with vulnerable plaque components in the carotid artery: the Rotterdam Study
Blerim Mujaj
European Journal of Endocrinology
View PDFchevron_right
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus
Arie Van Tol
Diabetologia, 2006
View PDFchevron_right
Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men
John Wikstrand
Stroke, 2004
View PDFchevron_right
Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases
Liliana Mannucci
International Journal of Immunopathology and Pharmacology, 2019
View PDFchevron_right
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
J. David Spence
Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
View PDFchevron_right
Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients
Fabian Schmid
European Journal of Clinical Investigation, 2006
View PDFchevron_right
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study
Sarah Knox
Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
View PDFchevron_right
A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences
Recep Yurtal
Atherosclerosis, 2007
View PDFchevron_right
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study
Mohammed Saad
Diabetes Care, 2000
View PDFchevron_right
Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
Djordje Radak
BMC Cardiovascular Disorders
View PDFchevron_right